| 1. |
- Arthur, J, et al.
(författare)
-
The dishonourable disobedience of not providing abortion
- 2017
-
Ingår i: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception. - : Informa UK Limited. - 1473-0782. ; 22:1, s. 81-81
-
Tidskriftsartikel (refereegranskat)
|
|
| 2. |
- Baath, M, et al.
(författare)
-
Somatostatin receptor scintigraphy with 99mTc-Depreotide (NeoSpect) in discriminating between malignant and benign lesions in the diagnosis of lung cancer: a pilot study
- 2004
-
Ingår i: Acta radiologica (Stockholm, Sweden : 1987). - : SAGE Publications. - 0284-1851 .- 1600-0455. ; 45:8, s. 833-839
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: To evaluate the diagnostic value of a new somatostatin analog, 99mTc-Depreotide, in differentiating benign from malignant lesions in patients with pulmonary nodules or masses. Material and Methods: A pilot study was performed on 28 patients referred to our Lung Department on suspicion of lung cancer. A chest X-ray, computed tomography (CT) of the thorax and upper abdomen, and scintigraphy were done - scintigraphy following the administration of 740 MBq 99mTc-Depreotide. Planar and tomographical imaging of the thorax and whole-body scanning with a gamma camera were done, and diagnostic outcome of the scintigrams was compared to CT, pathology, and clinical outcome. Results: Of 21 patients who had a focal high uptake of Depreotide, 17 were malignancies. One patient had two lesions with high Depreotide uptake, lung cancer, and pneumonia in the contralateral lung. Two patients with sarcoidosis and one with bilateral round atelectasis also had high Depreotide uptake bilaterally. Seven of the 8 patients with no uptake were true negative: 5 hamartomas and 2 round atelectases. One small lung cancer in the pleura sinus did not have Depreotide uptake. Conclusion: The somastotatin analog Depreotide is promising for discriminating between malignant and benign lung lesions.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Bull, JR, et al.
(författare)
-
Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles
- 2019
-
Ingår i: NPJ digital medicine. - : Springer Science and Business Media LLC. - 2398-6352. ; 2, s. 83-
-
Tidskriftsartikel (refereegranskat)abstract
- The use of apps that record detailed menstrual cycle data presents a new opportunity to study the menstrual cycle. The aim of this study is to describe menstrual cycle characteristics observed from a large database of cycles collected through an app and investigate associations of menstrual cycle characteristics with cycle length, age and body mass index (BMI). Menstrual cycle parameters, including menstruation, basal body temperature (BBT) and luteinising hormone (LH) tests as well as age and BMI were collected anonymously from real-world users of the Natural Cycles app. We analysed 612,613 ovulatory cycles with a mean length of 29.3 days from 124,648 users. The mean follicular phase length was 16.9 days (95% CI: 10–30) and mean luteal phase length was 12.4 days (95% CI: 7–17). Mean cycle length decreased by 0.18 days (95% CI: 0.17–0.18, R2 = 0.99) and mean follicular phase length decreased by 0.19 days (95% CI: 0.19–0.20, R2 = 0.99) per year of age from 25 to 45 years. Mean variation of cycle length per woman was 0.4 days or 14% higher in women with a BMI of over 35 relative to women with a BMI of 18.5–25. This analysis details variations in menstrual cycle characteristics that are not widely known yet have significant implications for health and well-being. Clinically, women who wish to plan a pregnancy need to have intercourse on their fertile days. In order to identify the fertile period it is important to track physiological parameters such as basal body temperature and not just cycle length.
|
|
| 6. |
- Bygdeman, M, et al.
(författare)
-
Contraceptive use of antiprogestin
- 1999
-
Ingår i: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception. - : Informa UK Limited. - 1362-5187. ; 4:2, s. 103-7
-
Tidskriftsartikel (refereegranskat)
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
- Bygdeman, M, et al.
(författare)
-
Pregnancy termination
- 2000
-
Ingår i: Steroids. - 0039-128X. ; 65:10-11, s. 801-805
-
Tidskriftsartikel (refereegranskat)
|
|
| 10. |
|
|
| 11. |
|
|
| 12. |
|
|
| 13. |
|
|
| 14. |
|
|
| 15. |
|
|
| 16. |
|
|
| 17. |
|
|
| 18. |
|
|
| 19. |
|
|
| 20. |
|
|
| 21. |
|
|
| 22. |
|
|
| 23. |
|
|
| 24. |
- Danielsson, KG
(författare)
-
What to do when it fails? Termination
- 2022
-
Ingår i: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. - : Elsevier BV. - 0301-2115. ; 273, s. E14-E14
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)
|
|
| 25. |
|
|
| 26. |
|
|
| 27. |
|
|
| 28. |
|
|
| 29. |
|
|
| 30. |
|
|
| 31. |
|
|
| 32. |
|
|
| 33. |
|
|
| 34. |
|
|
| 35. |
|
|
| 36. |
- Fiala, C, et al.
(författare)
-
Rh-prophylaxis in early abortion
- 2003
-
Ingår i: Acta obstetricia et gynecologica Scandinavica. - : Wiley. - 0001-6349. ; 82:10, s. 892-903
-
Tidskriftsartikel (refereegranskat)
|
|
| 37. |
|
|
| 38. |
|
|
| 39. |
|
|
| 40. |
|
|
| 41. |
|
|
| 42. |
|
|
| 43. |
|
|
| 44. |
|
|
| 45. |
|
|
| 46. |
|
|
| 47. |
|
|
| 48. |
|
|
| 49. |
|
|
| 50. |
|
|
